James D Pipkin

Title: The Innovations of James D. Pipkin

Introduction

James D. Pipkin is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly with his work on aztreonam, an important antibiotic. His innovative approach has led to the development of a unique crystalline form of this compound.

Latest Patents

James D. Pipkin holds one patent for his invention titled "Crystalline anhydrous aztreonam." This patent describes the preparation of the crystalline anhydrous form of [3S-[3.alpha.(Z), 4.beta.]]-3-[[(2-amino-4-thiazolyl) [(1-carboxy-1-methylethoxy)imino]acetyl]amino]-4-methyl-2-oxo-1-azetidinesulfonic acid. This invention represents a significant advancement in the formulation of aztreonam, enhancing its stability and efficacy.

Career Highlights

James D. Pipkin is associated with E.R. Squibb & Sons, Inc., a company known for its commitment to pharmaceutical innovation. His work at this organization has allowed him to focus on developing new and improved drug formulations that can benefit patients worldwide.

Collaborations

Throughout his career, James has collaborated with several talented individuals, including David M. Floyd and Octavian R. Kocy. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking pharmaceutical solutions.

Conclusion

James D. Pipkin's contributions to the field of pharmaceuticals, particularly through his patent on crystalline anhydrous aztreonam, highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the industry and pave the way for future advancements.